Nastech Pharmaceutical Company, Inc.

Marina Biotech utilizes its diverse nucleic acid drug discovery engine, rapidly moving novel oligonucleotide compounds into clinical development for rare disorders.

Marina Biotech, nucleic acid therapeutics, rare disease treatment, Familial Adenomatous Polyposis, orphan disease treatment, single-stranded nucleic acid payload, double-stranded nucleic acid payload, nucleic acid delivery technology